Cheng, Jie
Li, Wenxin
Kang, Bo
Zhou, Yanwen
Song, Jiasheng
Dan, Songsong
Yang, Ying
Zhang, Xiaoqian
Li, Jingchao
Yin, Shengyong
Cao, Hongcui
Yao, Hangping
Zhu, Chenggang
Yi, Wen
Zhao, Qingwei
Xu, Xiaowei
Zheng, Min
Zheng, Shusen
Li, Lanjuan
Shen, Binghui
Wang, Ying-Jie
Article History
Received: 27 February 2015
Accepted: 17 April 2015
First Online: 10 June 2015
Competing interests
: J.S. is a major stakeholder and Chief Scientific Officer of the AhR Pharmaceuticals Inc. The remaining authors declare no competing financial interests.